Sponsored Links
| New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinson's Disease And Movement Disorders (MDS) |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Merz Pharmaceuticals announced that new data on Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from accessory (complexing) proteins, will be presented at the Movement Disorder Society's (MDS) 15th International Congress of Parkinson's Disease and Movement Disorders in Toronto, Canada... Read more: Pharma Industry / Biotech Industry News From Medical News Today
|